LVW Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $958K | Sell |
13,876
-1,422
| -9% | -$98.1K | 0.1% | 113 |
|
2025
Q1 | $1.06M | Buy |
15,298
+1,145
| +8% | +$79.5K | 0.13% | 98 |
|
2024
Q4 | $1.22M | Sell |
14,153
-1,091
| -7% | -$93.8K | 0.15% | 94 |
|
2024
Q3 | $1.82M | Sell |
15,244
-1,397
| -8% | -$166K | 0.23% | 65 |
|
2024
Q2 | $2.38M | Buy |
16,641
+223
| +1% | +$31.8K | 0.35% | 43 |
|
2024
Q1 | $2.11M | Sell |
16,418
-624
| -4% | -$80.1K | 0.36% | 46 |
|
2023
Q4 | $1.76M | Sell |
17,042
-710
| -4% | -$73.5K | 0.33% | 52 |
|
2023
Q3 | $1.61M | Sell |
17,752
-5,138
| -22% | -$467K | 0.33% | 61 |
|
2023
Q2 | $1.85M | Sell |
22,890
-694
| -3% | -$56.2K | 0.36% | 61 |
|
2023
Q1 | $1.88M | Buy |
23,584
+252
| +1% | +$20.1K | 0.37% | 62 |
|
2022
Q4 | $1.58M | Sell |
23,332
-3,850
| -14% | -$261K | 0.32% | 69 |
|
2022
Q3 | $1.35M | Sell |
27,182
-1,234
| -4% | -$61.5K | 0.3% | 67 |
|
2022
Q2 | $1.58M | Buy |
28,416
+4,008
| +16% | +$223K | 0.32% | 63 |
|
2022
Q1 | $1.36M | Sell |
24,408
-9,112
| -27% | -$506K | 0.23% | 71 |
|
2021
Q4 | $1.88M | Sell |
33,520
-1,174
| -3% | -$65.7K | 0.32% | 66 |
|
2021
Q3 | $1.67M | Sell |
34,694
-504
| -1% | -$24.2K | 0.29% | 66 |
|
2021
Q2 | $1.47M | Sell |
35,198
-86
| -0.2% | -$3.6K | 0.26% | 68 |
|
2021
Q1 | $1.19M | Buy |
35,284
+4,688
| +15% | +$158K | 0.23% | 70 |
|
2020
Q4 | $1.07M | Sell |
30,596
-322
| -1% | -$11.3K | 0.21% | 69 |
|
2020
Q3 | $1.07M | Sell |
30,918
-3,640
| -11% | -$126K | 0.24% | 67 |
|
2020
Q2 | $1.13M | Buy |
34,558
+1,516
| +5% | +$49.6K | 0.27% | 60 |
|
2020
Q1 | $995K | Buy |
33,042
+10,838
| +49% | +$326K | 0.26% | 65 |
|
2019
Q4 | $643K | Buy |
22,204
+8,478
| +62% | +$246K | 0.15% | 89 |
|
2019
Q3 | $355K | Buy |
+13,726
| New | +$355K | 0.09% | 114 |
|